Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Psychooncology. 2014 Jun 14;24(5):523–532. doi: 10.1002/pon.3606

Table 4.

Multivariable Logistic Regression for Exposure to SSRI/SNRIs

Covariate Level OR 95% CI P value
Depression Diathesis
Depression Symptoms* Yes vs. no 1.68 1.29 2.19 <0.001
Family history of depression Yes vs. no 2.15 1.79 2.57 <0.001
Comorbidity Indicators
Number of medicines currently taking 5–9 vs. 0–4 2.20 1.57 3.08 <0.001
10 vs. 0–4 3.32 2.33 4.73 <0.001
Missing vs. 0–4 1.54 1.03 2.31 0.036
Pain management index Adequately vs. under-treated 1.07 0.82 1.40 0.605
Missing vs. under-treated 1.83 1.10 3.05 0.020
Exposure to steroids Yes vs. no 0.76 0.56 1.04 0.086
Exposure to beta-blockers Yes vs. no 0.86 0.69 1.07 0.171
Exposure to anxiolytics Yes vs. no 2.04 1.62 2.58 <0.001
Exposure to sedatives Yes vs. no 2.10 1.42 3.10 <0.001
Cancer Treatment Status
Current cancer therapy Within 1 month vs. no 0.81 0.59 1.12 0.206
Within 1 year vs. no 0.89 0.67 1.18 0.418
>1 year vs. no 1.58 1.19 2.11 0.002
Prior systemic therapy Yes vs. no 1.49 1.18 1.89 0.001
Prior radiotherapy Yes vs. no 1.12 0.89 1.40 0.334
Clinical and Demographic Factors
Race/Ethnicity Other vs. Non-Hispanic White 0.49 0.34 0.71 <0.001
Sex Male vs. female 0.54 0.40 0.73 <0.001
Age <55 vs.55 1.24 1.00 1.53 0.046
Duration of cancer Continuous (years) 0.99 0.97 1.02 0.451
Disease status Advanced vs. Non-advanced 0.88 0.74 1.04 0.123
ECOG PS 1–4 vs. 0 0.92 0.74 1.15 0.454
Weight loss in past 6 months >5% vs. ≤5% 0.83 0.57 1.21 0.341
Participation in a support group Yes vs. no 1.12 0.79 1.59 0.522
Participation in counseling service Yes vs. no 1.61 1.02 2.54 0.041
Perceived QOL Poor vs. good 1.32 1.05 1.65 0.016
Type of institution CCOP vs. academic 1.80 1.14 2.83 0.012
MBCCOP vs. academic 1.47 0.78 2.80 0.236

Abbreviations: OR: odds ratio, CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status; QOL, quality of life; CCOP, Community Clinical Oncology Program; MBCCOP, Minority-Based Community Clinical Oncology Program

*

Depressive symptoms defined as combined results from case-finding categories 1–5 (depressive by any method).